(Q43649399)

25 November 2017

title

Trivalent inactivated influenza vaccine is not associated with sickle cell hospitalizations in adults from a large cohort (English)

1 reference

25 November 2017

0 references

1 reference

1 reference

1

Simon J Hambidge

1 reference

25 November 2017

4

Jason Glanz

1 reference

25 November 2017

Colleen Ross

2

1 reference

25 November 2017

David McClure

series ordinal

3

1 reference

25 November 2017

VSD team

series ordinal

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

17 September 2011

1 reference

25 November 2017

1 reference

25 November 2017

volume

29

1 reference

25 November 2017

issue

46

1 reference

25 November 2017

page(s)

8179-8181

1 reference

Population estimates of sickle cell disease in the U.S.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.002

Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.002

Infection in sickle cell disease: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.002

Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.002

The Vaccine Safety Datalink: a model for monitoring immunization safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.002

The Vaccine Safety Datalink project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.002

Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.002

Case series analysis of adverse reactions to vaccines: a comparative evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.002

Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.002

Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.002

Accuracy of data on influenza vaccination status at four Vaccine Safety Datalink sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.002

10.1016/J.VACCINE.2011.09.002

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference